Walleye Capital
TMDX icon

Walleye Capital’s Transmedics TMDX Stock Holding History

Walleye Capital’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$220K Buy
2,213
+561
+34% +$73.2K ﹤0.01% 3279
2025
Q4 		$201K Buy
+1,652
New +$207K ﹤0.01% 3544
2025
Q3 		– Sell
-1,564
Closed -$183K – 5129
2025
Q2 		$210K Buy
+1,564
New +$172K ﹤0.01% 3329
2025
Q1 		– Sell
-4,812
Closed -$331K – 5126
2024
Q4 		$300K Buy
4,812
+3,485
+263% +$324K ﹤0.01% 3431
2024
Q3 		$208K Sell
1,327
-12,376
-90% -$1.91M ﹤0.01% 3980
2024
Q2 		$2.06M Buy
+13,703
New +$1.64M ﹤0.01% 2064
2023
Q4 		– Sell
-96,091
Closed -$5.26M – 5516
2023
Q3 		$5.26M Buy
+96,091
New +$6.92M 0.01% 1002
2023
Q1 		– Sell
-11,105
Closed -$768K – 4366
2022
Q4 		$685K Sell
11,105
-42,843
-79% -$2.28M 0.01% 1237
2022
Q3 		$2.25M Buy
53,948
+33,255
+161% +$1.45M 0.04% 489
2022
Q2 		$651K Buy
+20,693
New +$552K 0.02% 863
2021
Q4 		– Sell
-12,454
Closed -$412 – 2319
2021
Q3 		$412 Buy
+12,454
New +$381K 0.01% 869

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's TMDX Position: Q1 2026 in Review

Walleye Capital increased its Transmedics (TMDX) stake by 34% in Q1 2026, buying an estimated $73.2K and bringing the position to 2,213 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #3279.

Walleye Capital first reported a position in TMDX in Q3 2021 and has held it in 11 quarters since. The position peaked at $5.26M in Q3 2023. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Walleye Capital held 2,213 shares of Transmedics worth $220K as of Q1 2026.
  • Walleye Capital bought 561 Transmedics shares in Q1 2026, an estimated $73.2K.
  • Transmedics made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3279 holding.
  • Walleye Capital first reported a position in Transmedics in Q3 2021 and has held it in 11 quarters since.
  • Walleye Capital's Transmedics position peaked at $5.26M in Q3 2023.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.